Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GRK5 | P34947 | 1/20 | 0.44 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.44 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11841199 | 0.89 | CA12 (0.50) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL370611 | 0.84 | KMT2A (0.64) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL11834938 | 0.80 | L3MBTL1 (0.39) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL11686284 | 0.80 | F2 (0.52) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL28493476 | 0.80 | FAAH (0.48) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL31070429 | 0.80 | LMNA (0.53) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL23841260 | 0.76 | KMT2A (0.65) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL718072 | 0.76 | KMT2A (0.63) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL15834910 | 0.75 | KMT2A (0.48) | KMT2AMEN1ALDH1A1CA12CA1 | |
| SCHEMBL11381745 | 0.75 | KMT2A (0.48) | KMT2AMEN1ALDH1A1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118598736-A | Synthesis method of alpha, beta-unsaturated carbonyl compound | 中山大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118515585-A | Synthesis method of alkenyl cyanide compound | 中山大学 | 2024-08-20 | — | — | CN | claimed |
| US-4001025-A | SILVER SULFIDE, DIGESTION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-01-04 | — | — | US | claimed |
| CN-118598736-A | Synthesis method of alpha, beta-unsaturated carbonyl compound | 中山大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118515585-A | Synthesis method of alkenyl cyanide compound | 中山大学 | 2024-08-20 | — | — | CN | disclosed |
| CN-106922129-B | Methods of conjugating polypeptides | 免疫医疗有限责任公司 | 2024-02-20 | — | — | CN | disclosed |
| EP-3200829-B1 | METHOD OF CONJUGATING A POLYPEPTIDE | MEDIMMUNE LLC (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-111848473-B | Aryl alkenyl thioether compound and preparation method thereof | 盐城工学院 | 2022-10-11 | — | — | CN | disclosed |
| US-20220160882-A1 | METHOD OF CONJUGATING A POLYPEPTIDE | MEDIMMUNE, LLC | 2022-05-26 | — | — | US | disclosed |
| CN-111848473-A | Aryl alkenyl thioether compound and preparation method thereof | 盐城工学院 | 2020-10-30 | — | — | CN | disclosed |
| US-20170304460-A1 | METHOD OF CONJUGATING A POLYPEPTIDE | MEDIMMUNE, LLC | 2017-10-26 | — | — | US | disclosed |
| EP-0005348-B1 | CARBAPENEM DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1982-09-22 | — | — | EP | disclosed |
| US-4342851-A | WITH A 2,4-DITHIOHYDANTOIN CROSSLINKING AGENT | OSAKA SODA CO. LTD. (JP) | 1982-08-03 | — | — | US | disclosed |
| EP-0052299-A1 | 2-Oxoazetidine derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4278686-A | ANTIBIOTICS | BEECHAM GROUP LIMITED (GB) | 1981-07-14 | — | — | US | disclosed |
| EP-0005348-A1 | Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1979-11-14 | — | — | EP | disclosed |
| EP-0005349-A1 | Alkylcarbapenems, their preparation, use in pharmaceutical compositions and intermediates | BEECHAM GROUP PLC (GB) | 1979-11-14 | — | — | EP | disclosed |
| US-4119780-A | 2(Isopropyldithio)benzimidazole | MONSANTO COMPANY (US) | 1978-10-10 | — | — | US | disclosed |
| US-4006155-A | Method for preparation of phosphorus polysulfides | MONSANTO COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
| US-4001025-A | SILVER SULFIDE, DIGESTION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170304460-A1 | METHOD OF CONJUGATING A POLYPEPTIDE | SHBG, PTMS, VIP | KMT2A 4577/4885MEN1 433/4885ALDH1A1 2001/4885 |
| US-20220160882-A1 | METHOD OF CONJUGATING A POLYPEPTIDE | ZYX, QPCT, MRPL21 | KMT2A 4558/4885MEN1 1187/4885ALDH1A1 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.